- STAT+: Your sepsis algorithm shouldn’t require a time machineIn this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.STAT · 1mo ago↗ source
- Ethyreal starts up with $101M and takes aim at a pair of immune diseases<figure><div><img src="https://imgproxy.divecdn.com/egbyTu8esim-VjYj5FTvMQUlBrndW-s35OSn02s-EoY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzk4NTE5MTYzLmpwZ…BioPharma Dive · 1mo ago↗ source
- Sanofi stops immune drug trial in latest research setback<p>The failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.</p>BioPharma Dive